ZANAVIR CA atazanavir 200 mg capsule blister pack

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

atazanavir sulfate, Quantity: 227.81 mg (Equivalent: atazanavir, Qty 200 mg)

Fáanlegur frá:

Cipla Australia Pty Ltd

INN (Alþjóðlegt nafn):

Atazanavir sulfate

Lyfjaform:

Capsule, hard

Samsetning:

Excipient Ingredients: lactose monohydrate; crospovidone; magnesium stearate; purified water; titanium dioxide; iron oxide red; Gelatin; sodium lauryl sulfate

Stjórnsýsluleið:

Oral

Einingar í pakka:

6 capsules

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

Atazanavir is indicated for the treatment of HIV 1 infection, in combination with other antiretroviral agents. This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts from controlled studies (See Clinical Trials).

Vörulýsing:

Visual Identification: White to pale yellow granules filled in size 0 hard gelatin capsule with maroon cap & white body spin printed with 'Cipla 200' on cap with white ink.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 15 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Leyfisstaða:

Licence status A

Leyfisdagur:

2017-08-30